Last Updated on October 11, 2022
Last Updated on September 25, 2020
A Call-to-Action for Biomarkers Development and Adoption
Related Articles
We did it! Act2SaveMoms has become a law December 22, 2018: This is a great day for preeclampsia and the beginning of the end of needless deaths. Late last night, President Trump...
TAKE ACTION Legislative advocacy simply means educating others about preeclampsia and hypertensive disorders of pregnancy, and helping to influence government policy. We have successfully fough...
Washington, DC – April 11, 2024 – On April 10, one day before the start of Black Maternal Health Week, the Preeclampsia Foundation in partnership with Thermo Fisher Diagnostics held a Hill...
In an opinion piece in The Hill (5/7), Rakhi Dimino, MD, a Houston-based obstetrician who serves on the Preeclampsia Foundation’s Board of Directors, writes that findings from two rece...
Preeclampsia Foundation signs bipartisan letter asking House leaders to include funding for a key Centers for Disease Control and Prevention (CDC) program that helps identify emerging threats to mothe...
The Preeclampsia Foundation announced its support for the Black Maternal Health Caucus’s (BMHC) Momnibus, a set of nine individual bills critically important to solving our nation's maternal hea...
This is a great day for preeclampsia and the beginning of the end of needless deaths. Late last night, President Trump signed into law the Preventing Maternal Deaths Act. We are very proud and incredi...